Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

LON/GENF stock hub

LON/GENF has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/GENFis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

12.9M

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/GENF

In the news

Latest news · LON/GENF

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.9P50 16.9P75 23.5

Trailing P/En/a

P25 15.9P50 22.9P75 35.8

ROEn/a

P25 -54.2P50 2.1P75 13.7

ROICn/a

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/GENF market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

134

Groups with data

Currency

GBP

Showing 134 of 134 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United Kingdom
Country code	UK
Employees	5
Employees Change	0%
Employees Change Percent	0
Enterprise value	GBX 12.7M
Exchange	London Stock Exchange
Financial currency	GBP
First seen	2026-05-10
Industry	Biotechnology
Isin	GB00BP2C3V08
Last refreshed	2026-05-10
Market cap	GBX 12.9M
Price	GBX 2.4
Price currency	GBX
Sector	Healthcare
Sic	2836
Symbol	lon/GENF
Website	https://genflowbio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-11.03%
EV Earnings	-8.99x
P/B ratio	-23.34x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	GBX -1.4M
Net Income Growth Quarters	2%
Net Income Growth Years	2%
Profit Per Employee	GBX -283,513
ROA	-211.4
ROCE	257.4

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	182.55%
Cagr3y	-10.29%
EPS Growth Quarters	3
EPS Growth Years	2
Revenue Growth Quarters	2x
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	GBX 452,386
Cash	GBX 111,792
Current Assets	GBX 466,853
Current Liabilities	GBX 771,384
Equity	GBX -550,785
Liabilities	GBX 1M
Long Term Assets	GBX -14,467
Long Term Liabilities	GBX 231,787
Net Cash	GBX 111,792
Net Cash By Market Cap	GBX 0.87
Net Cash Growth	-75.48%
Tangible Book Value	GBX -550,785
Tangible Book Value Per Share	GBX -0
WACC	17.23

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.45
Net Working Capital	GBX -663,643
Quick ratio	0.45
Working Capital	GBX -551,851

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-27.66%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	182.35%
200-day SMA	1.71
3Y total return	-27.82%
50-day SMA	2.14
50-day SMA vs 200-day SMA	50over200
All Time High	13.5
All Time High Change	-82.22%
All Time High Date	2022-02-02
All Time Low	0.55
All Time Low Change	336.36%
All Time Low Date	2025-07-17
ATR	0.32
Beta	2.36
Beta1y	-2.11
Beta2y	-0.61
Ch YTD	29.73
High	2.6
High52	3.12
High52 Date	2026-04-30
High52ch	-23.08%
Low	2.3
Low52	0.55
Low52 Date	2025-08-21
Low52ch	336.36%
Ma50ch	12.15%
Price vs 200-day SMA	40.19%
RSI	49.58
RSI Monthly	50.12
RSI Weekly	59.35
Sharpe ratio	1.26x
Sortino ratio	2.8
Total Return	-27.66%
Tr YTD	29.73
Tr1m	9.09%
Tr1w	-11.11%
Tr3m	14.29%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	GBX -1.4M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	295,909,908%
Shares Insiders	43.49%
Shares Institutions	32.54%
Shares Out	535,653,205
Shares Qo Q	9.53%
Shares Yo Y	27.66%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	2,473,299.8x
Bv Per Share	-0
Ch1m	9.09
Ch1w	-11.11
Ch1y	182.4
Ch3m	14.29
Ch3y	-27.82
Ch6m	15.66
Change	-7.69%
Change From Open	-7.69
Close	2.6
Days Gap	0
Depreciation Amortization	1,093
Dollar Volume	2,908,351.2
Earnings Date	2026-05-13
EBIT	GBX -1.4M
EBITDA	GBX -1.4M
EPS	GBX -0
F Score	0
Financing CF	1,308,698
Fiscal Year End	December
Founded	2,020
Is Primary Listing	1
Last Earnings Date	2025-12-30
Last Report Date	2025-06-30
Ma150	1.98
Ma150ch	21.21%
Ma20	2.48
Ma20ch	-3.26%
Net CF	-166,890
Next Earnings Date	2026-05-13
Open	2.6
Position In Range	33.33
Ppne	1,528
Price Date	2026-05-08
Relative Volume	0.5x
Tr6m	15.66%
Volume	1,211,813

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does LON/GENF pay a dividend?

Capital-return profile for this ticker.

Performance

LON/GENF stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/GENF?

Insider, institutional, and short-interest positioning.

Institutional ownership

+32.5%

Share of float held by funds and institutions

Insider ownership

+43.5%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+27.7%

Negative means the company is buying back shares.

Technical

LON/GENF momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

49.6

Neutral momentum band

Price vs 200-day MA

+40.2%

50/200-day relationship not available

Beta (5Y)

2.36

More volatile than the market

Sharpe ratio

1.26

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/GENF

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/GENF stock rating?

lon/GENF is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/GENF analysis?

The full report lives at /stocks/lon/GENF/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/GENF?

The latest report frames lon/GENF around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/GENF page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.